Nlem

De-controlling drug prices: SC refuses to interfere in Centre's decision

The Supreme Court today refused to interfere with the Centre's decision to de-control prices of 108 cardiac and diabetes drugs saying the issue can be raised before the competent authority through representation.

Drug price debate; Don't cow down to pharma pressure, activists tell govt

Countering the industry’s claims that the decontrol of prices will cause an annual loss of revenues of over Rs.600 crores, activists note that NPPA’s action on the market will be marginal. It will affect only those brands that were selling at very high prices.

Prices of 440 essential drugs cut last month: Govt

There are 680 formulations under the National List of Essential Medicines (NLEM). Of these, the National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling prices in respect of 440 medicines as on June 30